BioTuesdays

Search results for - gtxi

Stifel nearly triples PT for GTx to $45 from $16

Stifel nearly tripled its price target for GTx (NASDAQ:GTXI) to $45 from $16 after the company reported significant positive new data at the SUFU Winter Meeting for its Phase 2 proof-of-concept study testing, enobosarm...

Stifel starts GTx at buy; PT $16

Stifel initiated coverage of GTx (NASDAQ:GTXI) a “buy” rating and $16 price target. The stock closed at $7.51 on Nov. 8. “We believe the Street is overlooking blockbuster potential for lead pipeline asset, enobosarm, in...